PharmiWeb.com - Global Pharma News & Resources
16-May-2023

Airway Management Devices Market is expected to surpass US$ 2.2 billion by 2033, with a CAGR of 3.6%

The Airway Management Devices Market Size is expected to be worth US$ 1.6 billion in 2023, with total revenue growing at a 3.6% CAGR from 2023 to 2033, reaching US$ 2.2 billion.

The market for Airway Management Devices was valued at US$ 1.5 billion in 2022, with a 3.2% CAGR expected over the forecast period. Absolute dollar growth in the global market is US$ 668.5 million.

The increased prevalence of respiratory illnesses is projected to be a major driving force in the market. According to the WHO, 65 million people have moderate-to-severe COPD. Furthermore, COPD is anticipated to be the third leading cause of death worldwide.

For Details on Vendors and Their Offerings – Request A Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-7775

This high incidence, combined with an increase in anaesthetic use as a result of numerous surgeries, is projected to fuel demand for advanced equipment, positively impacting market growth overall. The rising demand for emergency treatment for chronic illnesses, as well as long-term therapy for lung abnormalities in children and adults, is expected to drive market growth.

In the current scenario, rising awareness of poor ventilation and the implementation of reasonably improved preoperative airway assessment procedures are expected to extend the likelihood of product penetration in the coming years. For example, preoperative endoscopic airway evaluation (PEAE) aids in the identification and prediction of blocked ventilation, as well as the construction of an effective management approach that emphasises the use of modern equipment such as supraglottic airway.

Key Takeaways

  • Increased demand for emergency and intensive care is expected to drive the market.
  • The rising prevalence of respiratory disorders is expected to propel the market for Airway Management Devices forward.
  • In 2023, the market for Airway Management Devices is estimated to be worth US$ 1.6 billion.
  • The market for Airway Management Devices is expected to grow at a 3.6% CAGR between 2023 and 2033.
  • The market for Airway Management Devices is expected to be dominated by North America.

Last few days to get reports at discounted prices, offer expires soon!

Request Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-7775

Competitive Landscape

The global market for Airway Management Devices is highly concentrated, with a limited amount of large-scale vendors controlling the majority of market share. Key participants in the global market include:

  • Medtronic Plc
  • Teleflex Incorporated
  • Ambu A/S
  • Smith’s Group plc.
  • Intersurgical Ltd.
  • Cook Medical Inc.
  • SunMed
  • Vyaire Medical Inc
  • VBM Medizintechnik GmbH
  • Karl Storz SE & Co. KG
  • Cook Gas LLC
  • Flexicare (Group) Limited
  • BVLM Pty Ltd
  • Boston Medical Products Inc. (BESS GROUP)
  • Salter Labs

Recent Developments:

  • Verathon Inc. introduced the GlideScope Core 15 airway visualisation system in January 2020, which employs a 15-inch high-definition touchscreen monitor to provide improved visibility.
  • In January 2020, Smiths Medical, Inc. announced the expansion of its Portex Tracheostomy Tubes and Kits line by releasing a PVC-based tracheostomy tube range. The portfolio includes BLUperc, BLUselect tracheostomy tubes, and BLUgriggs percutaneous tracheostomy kits and trays.
  • Olympus Corporation, a global technology leader in inventing and delivering new solutions for surgical and medical procedures, among other core activities, announced the release of two video rhino-laryngoscopes in September 2019. It is proposed that the ENF-VH2/V4 be specially constructed for laryngological tests.
  • In September 2018, Royal Philips announced the development of a resuscitation device in conjunction with the Consortium for Affordable Medical Technologies (CAMTech) to aid in the reduction of infant mortality.
  • In January 2019, Oventus Medical, a medical device business, unveiled O2 Vent Optima, a new product. It is used to treat obstructive sleep apnea. It is based on the airway technology developed by Oventus Medical. It keeps the airway from contracting and allows for unrestricted airflow from the tongue, soft palate, and nose. It is suitable for usage with or without continuous positive airway pressure.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-7775

Airway Management Devices Market Key Segments

By Product Type:

  • Laryngeal Masks
  • Tracheostomy Tubes
  • Endotravheal Tubes
  • EndoBronhial Tubes
  • Nasal Airway Tubes
  • Oral Airway Tubes.

By Usage Type:

  • Single Use/ Disposable
  • Reusable

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

About Future Market Insights, Inc.

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs

Editor Details

Last Updated: 16-May-2023